13D Filing: Broadfin Capital and Novelion Therapeutics Inc. (NVLN)

CUSIP No.

67001K202

1.	NAME OF REPORTING PERSONS
	I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	Broadfin Capital, LLC

2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
		(a)	[_]
		(b)	[x]

3.	SEC USE ONLY

4.	SOURCE OF FUNDS
	AF, WC

5.	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)		[_]

6.	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

7.	SOLE VOTING POWER
	0

8.	SHARED VOTING POWER
	1,948,554*

9.	SOLE DISPOSITIVE POWER
	0

10.	SHARES DISPOSITIVE POWER
	1,948,554*

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
	PERSON
	1,948,554*

12.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES		[_]
	CERTAIN SHARES*

13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	10.42%

14.	TYPE OF REPORTING PERSON
	OO

* Please see Item 4 for description of certain restrictions pertaining
to the Reporting Persons’ exercise of the Warrants.